Oxymatrine reduces neuroinflammation in rat brain: A signaling pathway

Neural Regeneration Research

Volumn 7, Issue 30, 2012, Pages 2333-2339

  Mao, Jiahui ^a   Hu, Yae ^a   Zhou, Ailing ^a   Zheng, Bing ^b   Liu, Yi ^a   Du, Yueming ^a   Li, Jia ^a   Lu, Jinyang ^a   Zhou, Pengcheng ^a  

^a NANTONG UNIVERSITY   (China)

^b First People's Hospital of Nantong   (China)

Author keywords

Cerebral cortex; Hippocampus; Inflammatory factors; Lipopolysaccharide; Neural regeneration; Neuroinflammation; Nuclear factor B; Oxymatrine; Signaling pathway; Toll like receptor 4

Indexed keywords

EID: 84889016003     PISSN: 16735374     EISSN: 18767958     Source Type: Journal    
DOI: 10.3969/j.issn.1673-5374.2012.30.002     Document Type: Article

References (29)

1. [1] Amor S, Puentes F, Baker D, et al. Inflammation in neurodegenerative diseases. Immunology. 2010;129(2): 154-169.
2. [2] Lee SJ, Lee S. Toll-like receptors and inflammation in the CNS. Curr Drug Targets Inflamm Allergy. 2002;1(2): 181-191.
3. [3] Takeda K, Akira S. TLR signaling pathways. Semin Immunol. 2004;16(1):3-9.
4. [4] Liu Y, Zhang XJ, Yang CH, et al. Oxymatrine protects rat brains against permanent focal ischemia and downregulates NF-kappaB expression. Brain Res. 2009; 1268:174-180.
5. [5] Cao CX, Yang QW, Lv FL, et al. Reduced cerebral ischemia-reperfusion injury in Toll-like receptor 4 deficient mice. Biochem Biophys Res Commun. 2007;353(2): 509-514.
6. [6] Lu LG, Zeng MD, Mao YM, et al. Oxymatrine therapy for chronic hepatitis B: a randomized double-blind and placebo-controlled multi-center trial. World J Gastroenterol. 2003;9(11):2480-2483.
7. [7] Leker RR, Shohami E. Cerebral ischemia and trauma-different etiologies yet similar mechanisms: neuroprotective opportunities. Brain Res Brain Res Rev. 2002;39(1):55-73.
8. [8] O'Shea JJ, Ma A, Lipsky P. Cytokines and autoimmunity. Nat Rev Immunol. 2002;2(1):37-45.
9. [9] Quan N, Sundar SK, Weiss JM. Induction of interleukin-1 in various brain regions after peripheral and central injections of lipopolysaccharide. J Neuroimmunol. 1994; 49(1-2):125-134.
10. [10] Tanaka S, Ide M, Shibutani T, et al. Lipopolysaccharideinduced microglial activation induces learning and memory deficits without neuronal cell death in rats. J Neurosci Res. 2006;83(4):557-566.
11. [11] Cui CA, Jin DQ, Hwang YK, et al. Macelignan attenuates LPS-induced inflammation and reduces LPS-induced spatial learning impairments in rats. Neurosci Lett. 2008;448(1):110-114.
12. [12] Herber DL, Mercer M, Roth LM, et al. Microglial activation is required for Abeta clearance after intracranial injection of lipopolysaccharide in APP transgenic mice. J Neuroimmune Pharmacol. 2007;2(2):222-231.
13. [13] Lehnardt S, Massillon L, Follett P, et al. Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A. 2003;100(14):8514-8519.
14. [14] Sen R, Baltimore D. Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism. Cell. 1986;47(6):921-928.
15. [15] Gilmore TD. Introduction to NF-kappaB: players, pathways, perspectives. Oncogene. 2006;25(51): 6680-6684.
16. [16] Karin M, Greten FR. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol. 2005;5(10):749-759.
17. [17] Li Q, Verma IM. NF-kappaB regulation in the immune system. Nat Rev Immunol. 2002;2(10):725-734.
18. Ghosh S, Karin M. Missing pieces in the NF-kappaB puzzle. Cell. 2002;109 Suppl:S81-96.
19. [19] Baeuerle PA, Baltimore D. NF-kappa B: ten years after. Cell. 1996;87(1):13-20.
20. [20] Lucas PC, McAllister-Lucas LM, Nunez G. NF-kappaB signaling in lymphocytes: a new cast of characters. J Cell Sci. 2004;117(Pt 1):31-39.
21. [21] Beauparlant P, Hiscott J. Biological and biochemical inhibitors of the NF-kappa B/Rel proteins and cytokine synthesis. Cytokine Growth Factor Rev. 1996;7(2): 175-190.
22. [22] Hong-Li S, Lei L, Lei S, et al. Cardioprotective effects and underlying mechanisms of oxymatrine against Ischemic myocardial injuries of rats. Phytother Res. 2008;22(7): 985-989.
23. [23] Liu F, Liu J, Chen X, et al. Effect of oxymatrine on inflammation and its mechanism. Jilin Daxue Xuebao: Yixue Ban. 2005;31(5):728-730.
24. [24] Chen G, Zhang S, Shi J, et al. Simvastatin reduces secondary brain injury caused by cortical contusion in rats: possible involvement of TLR4/NF-kappaB pathway. Exp Neurol. 2009;216(2):398-406.
25. The Ministry of Science and Technology of the People’s Republic of China. Guidance Suggestions for the Care and Use of Laboratory Animals. 2006-09-30.
26. [26] Sharma M, Gupta YK. Intracerebroventricular injection of streptozotocin in rats produces both oxidative stress in the brain and cognitive impairment. Life Sci. 2001;68(9): 1021-1029.
27. [27] Paxions G, Watson C. The Rat Brain in Stereotaxic Coordinates. Beijing: People’s Medical Publishing House. 2005.
28. [28] Fan H, Li L, Zhang X, et al. Oxymatrine downregulates TLR4, TLR2, MyD88, and NF-kappaB and protects rat brains against focal ischemia. Mediators Inflamm. 2009;2009:704-706.
29. [29] Li X, Kong H, Wu W, et al. Aquaporin-4 maintains ependymal integrity in adult mice. Neuroscience. 2009;162(1):67-77.